TY - JOUR AU - Cornelissen, J. J. AU - Gratwohl, A. AU - Schlenk, R. F. PY - 2012 DA - 2012// TI - The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach JO - Nat Rev Clin Oncol VL - 9 UR - https://doi.org/10.1038/nrclinonc.2012.150 DO - 10.1038/nrclinonc.2012.150 ID - Cornelissen2012 ER - TY - JOUR AU - Wang, Y. AU - Chang, Y. J. AU - Xu, L. P. PY - 2014 DA - 2014// TI - Who is the best donor for a related HLA haplotype-mismatched transplant? JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-03-563130 DO - 10.1182/blood-2014-03-563130 ID - Wang2014 ER - TY - JOUR AU - McCurdy, S. R. AU - Kanakry, J. A. AU - Showel, M. M. PY - 2015 DA - 2015// TI - Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2015-01-623991 DO - 10.1182/blood-2015-01-623991 ID - McCurdy2015 ER - TY - JOUR AU - Wang, Y. AU - Liu, Q. F. AU - Xu, L. P. PY - 2015 DA - 2015// TI - Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2015-02-627786 DO - 10.1182/blood-2015-02-627786 ID - Wang2015 ER - TY - JOUR AU - Walker, I. AU - Panzarella, T. AU - Couban, S. PY - 2016 DA - 2016// TI - Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(15)00462-3 DO - 10.1016/S1470-2045(15)00462-3 ID - Walker2016 ER - TY - JOUR AU - Kroger, N. AU - Solano, C. AU - Wolschke, C. PY - 2016 DA - 2016// TI - Antilymphocyte globulin for prevention of chronic graft-versus-host disease JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1506002 DO - 10.1056/NEJMoa1506002 ID - Kroger2016 ER - TY - JOUR AU - Piemontese, S. AU - Ciceri, F. AU - Labopin, M. PY - 2017 DA - 2017// TI - A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0394-2 DO - 10.1186/s13045-017-0394-2 ID - Piemontese2017 ER - TY - JOUR AU - Shimoni, A. AU - Labopin, M. AU - Savani, B. PY - 2016 DA - 2016// TI - Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0347-1 DO - 10.1186/s13045-016-0347-1 ID - Shimoni2016 ER - TY - JOUR AU - Chang, Y. J. AU - Huang, X. J. PY - 2016 DA - 2016// TI - Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience JO - Semin Hematol VL - 53 UR - https://doi.org/10.1053/j.seminhematol.2016.01.004 DO - 10.1053/j.seminhematol.2016.01.004 ID - Chang2016 ER - TY - JOUR AU - Chang, Y. J. AU - Luznik, L. AU - Fuchs, E. J. AU - Huang, X. J. PY - 2016 DA - 2016// TI - How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0265-2 DO - 10.1186/s13045-016-0265-2 ID - Chang2016 ER - TY - JOUR AU - Milano, F. AU - Gooley, T. AU - Wood, B. PY - 2016 DA - 2016// TI - Cord-blood transplantation in patients with minimal residual disease JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1602074 DO - 10.1056/NEJMoa1602074 ID - Milano2016 ER - TY - JOUR AU - Chen, X. AU - Xie, H. AU - Wood, B. L. PY - 2015 DA - 2015// TI - Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.3518 DO - 10.1200/JCO.2014.58.3518 ID - Chen2015 ER - TY - JOUR AU - Freeman, S. D. AU - Virgo, P. AU - Couzens, S. PY - 2013 DA - 2013// TI - Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.49.1753 DO - 10.1200/JCO.2013.49.1753 ID - Freeman2013 ER - TY - JOUR AU - Walter, R. B. AU - Gyurkocza, B. AU - Storer, B. E. PY - 2015 DA - 2015// TI - Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.173 DO - 10.1038/leu.2014.173 ID - Walter2015 ER - TY - JOUR AU - Zhou, Y. AU - Othus, M. AU - Araki, D. PY - 2016 DA - 2016// TI - Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via multiparameter flow cytometry in adult acute myeloid leukemia JO - Leukemia VL - 30 UR - https://doi.org/10.1038/leu.2016.46 DO - 10.1038/leu.2016.46 ID - Zhou2016 ER - TY - JOUR AU - Walter, R. B. AU - Buckley, S. A. AU - Pagel, J. M. PY - 2013 DA - 2013// TI - Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-06-506725 DO - 10.1182/blood-2013-06-506725 ID - Walter2013 ER - TY - STD TI - Oran B, Jorgensen JL, Marin D, et al. Pretransplantion minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica. 2017;102(1):110-7. ID - ref17 ER - TY - JOUR AU - Walter, R. B. AU - Gooley, T. A. AU - Wood, B. L. PY - 2011 DA - 2011// TI - Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.8121 DO - 10.1200/JCO.2010.31.8121 ID - Walter2011 ER - TY - JOUR AU - Araki, D. AU - Wood, B. L. AU - Othus, M. PY - 2016 DA - 2016// TI - Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission? JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.63.3826 DO - 10.1200/JCO.2015.63.3826 ID - Araki2016 ER - TY - JOUR AU - Ustun, C. AU - Courville, E. L. AU - DeFor, T. PY - 2016 DA - 2016// TI - Myeloablative, but not reduced-intensity, conditioning overcomes the negative effect of flow-cytometric evidence of leukemia in acute myeloid leukemia JO - Biol Blood Marrow Transplant VL - 22 UR - https://doi.org/10.1016/j.bbmt.2015.10.024 DO - 10.1016/j.bbmt.2015.10.024 ID - Ustun2016 ER - TY - JOUR AU - Wang, Y. AU - Liu, D. H. AU - Xu, L. P. PY - 2011 DA - 2011// TI - Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison JO - Biol Blood Marrow Transplant VL - 17 UR - https://doi.org/10.1016/j.bbmt.2010.08.023 DO - 10.1016/j.bbmt.2010.08.023 ID - Wang2011 ER - TY - JOUR AU - Huang, X. J. AU - Liu, D. H. AU - Liu, K. Y. AU - Xu, L. P. AU - Chen, H. AU - Han, W. PY - 2007 DA - 2007// TI - Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation JO - Haematologica VL - 92 UR - https://doi.org/10.3324/haematol.10570 DO - 10.3324/haematol.10570 ID - Huang2007 ER - TY - JOUR AU - Chang, Y. J. AU - Xu, L. P. AU - Wang, Y. PY - 2016 DA - 2016// TI - Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.63.8817 DO - 10.1200/JCO.2015.63.8817 ID - Chang2016 ER - TY - JOUR AU - Yan, C. H. AU - Wang, Y. AU - Wang, J. Z. PY - 2016 DA - 2016// TI - Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0319-5 DO - 10.1186/s13045-016-0319-5 ID - Yan2016 ER - TY - JOUR AU - Yan, C. H. AU - Liu, D. H. AU - Liu, K. Y. PY - 2012 DA - 2012// TI - Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-09-380386 DO - 10.1182/blood-2011-09-380386 ID - Yan2012 ER - TY - JOUR AU - Wood, B. L. PY - 2013 DA - 2013// TI - Flow cytometric monitoring of residual disease in acute leukemia JO - Methods Mol Biol VL - 999 UR - https://doi.org/10.1007/978-1-62703-357-2_8 DO - 10.1007/978-1-62703-357-2_8 ID - Wood2013 ER - TY - JOUR AU - Wood, B. L. PY - 2007 DA - 2007// TI - Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia JO - Clin Lab Med VL - 27 UR - https://doi.org/10.1016/j.cll.2007.05.006 DO - 10.1016/j.cll.2007.05.006 ID - Wood2007 ER - TY - JOUR AU - Vecchio, L. AU - Brando, B. AU - Lanza, F. PY - 2004 DA - 2004// TI - Recommended reporting format for flow cytometry diagnosis of acute leukemia JO - Haematologica VL - 89 ID - Vecchio2004 ER - TY - JOUR AU - Feller, N. AU - Velden, V. H. AU - Brooimans, R. A. PY - 2013 DA - 2013// TI - Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting JO - Blood Cancer J VL - 3 UR - https://doi.org/10.1038/bcj.2013.27 DO - 10.1038/bcj.2013.27 ID - Feller2013 ER - TY - JOUR AU - Buccisano, F. AU - Maurillo, L. AU - Principe, M. I. PY - 2012 DA - 2012// TI - Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-08-363291 DO - 10.1182/blood-2011-08-363291 ID - Buccisano2012 ER - TY - JOUR AU - Wang, Y. AU - Fu, H. X. AU - Liu, D. H. PY - 2014 DA - 2014// TI - Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial JO - Bone Marrow Transplant VL - 49 UR - https://doi.org/10.1038/bmt.2013.191 DO - 10.1038/bmt.2013.191 ID - Wang2014 ER - TY - JOUR AU - Filipovich, A. H. AU - Weisdorf, D. AU - Pavletic, S. PY - 2005 DA - 2005// TI - National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report JO - Biol Blood Marrow Transplant VL - 11 UR - https://doi.org/10.1016/j.bbmt.2005.09.004 DO - 10.1016/j.bbmt.2005.09.004 ID - Filipovich2005 ER - TY - JOUR AU - Dabas, R. AU - Lee, R. AU - Servito, M. T. PY - 2016 DA - 2016// TI - Antithymocyte globulin at clinically relevant concentrations kills leukemic blasts JO - Biol Blood Marrow Transplant VL - 22 UR - https://doi.org/10.1016/j.bbmt.2016.01.002 DO - 10.1016/j.bbmt.2016.01.002 ID - Dabas2016 ER - TY - JOUR AU - Mo, X. D. AU - Xu, L. P. AU - Zhang, X. H. PY - 2015 DA - 2015// TI - Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome JO - Bone Marrow Transplant VL - 50 UR - https://doi.org/10.1038/bmt.2014.223 DO - 10.1038/bmt.2014.223 ID - Mo2015 ER - TY - JOUR AU - Kohnke, T. AU - Sauter, D. AU - Ringel, K. PY - 2015 DA - 2015// TI - Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.186 DO - 10.1038/leu.2014.186 ID - Kohnke2015 ER - TY - JOUR AU - Mo, X. D. AU - Zhang, X. H. AU - Xu, L. P. PY - 2016 DA - 2016// TI - Unmanipulated haploidentical hematopoietic stem cell transplantation in first complete remission can abrogate the poor outcomes of children with acute myeloid leukemia resistant to the first course of induction chemotherapy JO - Biol Blood Marrow Transplant VL - 22 UR - https://doi.org/10.1016/j.bbmt.2016.09.004 DO - 10.1016/j.bbmt.2016.09.004 ID - Mo2016 ER -